Search

everythinglearnresearchcommunity

for

Search:↓

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Alarmin cytokines are key in controlling skin immunity and inflammation.

More research is needed to understand and treat morphea effectively.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Children with atopic diseases have a higher risk of developing alopecia areata.

Pharmaceutical supply chains need stronger strategies and collaboration to ensure continuous medical product supply during pandemics.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Current treatments for neutrophilic alopecias in children are limited and often ineffective, especially for males and those of Afro-Caribbean descent.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.